Morgan Stanley set a €39.00 ($45.35) target price on Siemens Healthineers (ETR:SHL) in a research report released on Friday, Borsen Zeitung reports. The firm currently has a sell rating on the stock.
Several other research firms have also commented on SHL. Royal Bank of Canada set a €36.00 ($41.86) price target on shares of Siemens Healthineers and gave the company a neutral rating in a research report on Monday, November 4th. Berenberg Bank set a €42.00 ($48.84) price objective on shares of Siemens Healthineers and gave the stock a buy rating in a research report on Monday, November 4th. Barclays set a €38.00 ($44.19) price objective on shares of Siemens Healthineers and gave the stock a neutral rating in a research report on Thursday, November 7th. UBS Group set a €37.00 ($43.02) price objective on shares of Siemens Healthineers and gave the stock a neutral rating in a research note on Monday, November 4th. Finally, DZ Bank reissued a buy rating on shares of Siemens Healthineers in a research report on Monday, November 4th. Two equities research analysts have rated the stock with a sell rating, eleven have issued a hold rating and four have assigned a buy rating to the company. The company has a consensus rating of Hold and an average price target of €39.61 ($46.06).
SHL opened at €42.95 ($49.94) on Friday. The business’s 50-day moving average is €41.34 and its two-hundred day moving average is €37.49. Siemens Healthineers has a 1 year low of €33.05 ($38.42) and a 1 year high of €44.80 ($52.09). The company has a debt-to-equity ratio of 46.32, a current ratio of 1.39 and a quick ratio of 1.00. The firm has a market capitalization of $42.95 billion and a PE ratio of 27.39.
Siemens Healthineers AG develops, manufactures, and distributes imaging, advanced therapies, and diagnostic products and services to healthcare providers worldwide. It operates in three operating segments: Imaging, Advanced Therapies, and Diagnostics. The Imaging segment provides diagnostic imaging and ultrasound systems and solutions.
Featured Article: What are Closed-End Mutual Funds?
Receive News & Ratings for Siemens Healthineers Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Siemens Healthineers and related companies with MarketBeat.com's FREE daily email newsletter.